Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Najib Ben Khaled
Technische Universität München (TUM) - Institute of Molecular Oncology and Functional Genomics
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
32
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma: the IKF-t006/IMMUNIB translational phase-2 study NCT03841201
Number of pages: 27
Posted: 05 May 2026
Arndt Vogel
, Najib Ben Khaled,
Javier Ramirez
,
Garbiele Siebler
,
Jürgen Siebler
,
Udo Lindig
,
Silke Marhenke
,
Gregory Schwartz
,
Micheal Schultheiss
,
Tobias Mueller
,
Henry Simon
,
Enrico N. De Toni
,
Daniel Karl
,
Salah-Eddin Al-Batran
and
Anna Saborowski
Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology, Technische Universität München (TUM) - Institute of Molecular Oncology and Functional Genomics,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Ludwig Maximilian University of Munich (LMU),
affiliation not provided to SSRN
,
affiliation not provided to SSRN
and Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology
Downloads
32
(1,318,317)
View PDF
Download
Abstract:
advanced hepatocellular carcinoma, combination therapy, nivolumab, lenvatinib, 1st line
Feedback
